US+1 646-781-8004
Europe+44-203-868-8738
APAC+91-744-778-0008
sales@meticulousresearch.com
Home Report
Store
Precision Medicine Software Market
Precision Medicine Software Market by Deployment Mode (On-premise, Cloud-based), Application (Oncology, Pharmacogenomics, CNS), End User (Healthcare Providers, Research, Academia, Pharma, Biotech) - Forecast to 2028
Report ID:MRHC - 104305 Pages: 125 Apr-2021 Formats*: PDF Category: Healthcare Delivery: 2 to 4 HoursThe Precision Medicine Software Market is expected to grow at a CAGR of 11.2% from 2021 to 2028 to reach $2.55 billion by 2028. The paradigm shift in treatment, rising pressure to decrease healthcare costs, scientific & technological advances in the genomics field, and growing focus towards providing companion diagnostics & biomarkers for various therapeutic areas are some of the major factors expected to drive the growth of this market. However, the lack of awareness about precision medicine practices and fragmented healthcare systems in developing countries hinder the growth of this market to a certain extent.
Impact of COVID-19 on the Precision Medicine Software Market
With the healthcare industry facing a crisis amidst the pandemic, it has been working on various solutions to combat the pandemic. The healthcare industry is engaged in conducting precision medicine research to enable a better understanding of COVID-19 and to measure the impact caused by the virus to discover potential therapies. Many governments have taken initiatives to accelerate the use of precision medicine for coronavirus. For instance, in July 2020, the San Antonio Partnership for Precision Therapeutics announced funding of three collaborative COVID-19 research efforts in San Antonio. These projects will support a strong foundation of transformative COVID-19 research happening in San Antonio. Cleveland Clinic also launched a genomic medicine project to identify genetic factors that drive susceptibility to the virus and use these to develop prevention and therapeutic strategies against the virus. Emory University researchers are also investigating an antiviral compound that works like Remdesivir, which inhibits viral replication.
Apart from this, many research initiatives have been undertaken amidst the pandemic, thereby providing opportunities for the precision medicine software market in the upcoming years. For instance,
- A team at Texas Biomed is studying the role of a protein called furin that potentially impacts individual responses to COVID-19. There are indications that furin may be related to an increased risk of death from COVID-19 for individuals with underlying cardiovascular problems. Better understanding the role of furin and its unique effects on certain individuals may help develop patient-specific therapeutics that can be used to treat COVID-19. With the help of precision medicine, this study will understand why certain individuals have greater disease severity and why specific underlying conditions affect outcomes.
- A team at the University of Texas (UT) Health San Antonio is performing the second research initiative and examining how the COVID-19 virus evades the body's immune system and can block certain aspects of the immune system in some individuals. The team's goal is to identify antiviral compounds either among existing FDA-approved treatments or in vast libraries of drug-like molecules that could effectively combat the ability of the virus to evade the immune defense.
- The UT Health San Antonio is also studying specific pathways that allow the COVID-19 virus to evade the human immune system. This will allow researchers to understand how the disease caused by the virus behaves differently in different people.
Click here to: Get Free Sample Pages of this Report
Key Findings of the Global Precision Medicine Software Market Study:
In 2020, the on-premise segment dominated the precision medicine software market
Based on deployment mode, the global precision medicine software market is categorized into on-premise and web & cloud-based. In 2020, the on-premise segment accounted for the largest share of the global precision medicine software market. The large share of this segment is primarily attributed to the broad range of advantages associated with the use of on-premise software, such as high security of data, low risk of data breaches, and full command over software upgrades & data storage.
In 2020, the oncology segment accounted for the largest share of the global precision medicine software market
Based on application, the precision medicine software market is mainly segmented into oncology, pharmacogenomics, central nervous system disorders, hereditary disorders, and cardio & metabolic disorders. In 2020, the oncology segment accounted for the largest share of the global precision medicine software market. The large share of this segment is primarily attributed to the growing prevalence of cancer, shift towards personalized treatment, rising funding in cancer research, applications of precision medicine in oncology research, and increased investments by government organizations in precision medicine and related software industry.
In 2020, the healthcare providers segment accounted for the largest share of the global precision medicine software market
Based on end user, the global precision medicine software market is categorized into healthcare providers, research and government institutes, and pharmaceutical & biotechnology companies. In 2020, the healthcare providers segment accounted for the largest share of the global precision medicine software market. The large share of this segment is primarily attributed to the rising number of tertiary/specialty care hospitals, rising incidence of chronic diseases, growing healthcare infrastructure, increasing demand for quality healthcare, and shift towards personalized/precision medicine.
Asia-Pacific: Fastest-growing Market
Based on geography, the global precision medicine software market is categorized into five major regions, namely, North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa, with a further analysis of major countries in these regions. In 2020, North America accounted for the largest share of the global precision medicine software market. The Asia-Pacific region is expected to register the highest growth during the forecast period. The growing shift in treatment from one-size-fits-all medicines to precision medicine, increased spending on healthcare, rising funds for research activities, and growing focus of international players to expand their presence in this region are some of the key factors expected to propel the growth of the precision medicines software market in Asia-Pacific.
Key Players
The report includes the competitive landscape based on an extensive assessment of product portfolio, geographic presence, and key strategic developments adopted by leading market players in the industry over the past four years. The key players profiled in the global precision medicine software market are Syapse, Inc. (U.S.), Fabric Genomics, Inc. (U.S.), GenomOncology LLC (U.S.), SOPHiA GENETICS SA (Switzerland), Human Longevity, Inc. (U.S.), Sunquest Information Systems Inc. (U.S.), LifeOmic Health, LLC (U.S.), Translational Software Inc. (U.S.), N-of-One (U.S.), PhenoTips (Canada), PierianDx (U.S.), Foundation Medicine, Inc. (U.S.), and 2bPrecise (U.S.).
Scope of the Report:
Precision Medicine Software Market, by Delivery Mode
- On-premise
- Web & Cloud-based
Precision Medicine Software Market, by Application
- Oncology
- Pharmacogenomics
- Other Applications
Precision Medicine Software Market, by End User
- Healthcare Providers
- Research & Government Institutes
- Pharmaceutical & Biotechnology Companies
Precision Medicine Software Market, by Geography
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- U.K.
- Italy
- Spain
- Rest of Europe (RoE)
- Asia-Pacific (APAC)
- Japan
- China
- India
- Rest of APAC (RoAPAC)
- Latin America
- Middle East and Africa
Key questions answered in the report:
The precision medicine software market report covers the market size & forecasts for various products across geographies. The precision medicine software market studied in this report involves the value analysis of various segments and sub-segments of precision medicine software at the regional and country levels.
The global precision medicine software market is projected to reach $2.55 billion by 2028, at a CAGR of 11.2% during the forecast period of 2021-2028.
Based on deployment mode, the global precision medicine software market is categorized into on-premise and web & cloud-based. In 2020, the on-premise segment accounted for the largest share of 54.2% of the global precision medicine software market.
The paradigm shift in treatment, rising pressure to decrease healthcare costs, scientific & technological advances in the genomics field, growing focus towards providing companion diagnostics & biomarkers, and rising prevalence of cancer are the key factors supporting the growth of this market. In addition, emerging markets and AI in precision medicine are some of the factors that offer significant growth opportunities for players operating in this market.
The lack of awareness about precision medicine practices and fragmented healthcare systems in developing countries are expected to hinder the growth of the precision medicine software market during the forecast period.
The key players operating in the global precision medicine software market are Syapse, Inc. (U.S.), Fabric Genomics, Inc. (U.S.), GenomOncology LLC (U.S.), SOPHiA GENETICS SA (Switzerland), Human Longevity, Inc. (U.S.), Sunquest Information Systems Inc. (U.S.), LifeOmic Health, LLC (U.S.), Translational Software Inc. (U.S.), N-of-One (U.S.), PhenoTips (Canada), PierianDx (U.S.), Foundation Medicine, Inc. (U.S.), and 2bPrecise (U.S.) among others.
The large patient population demanding innovative diagnosis & treatment options, developing healthcare infrastructure, rising research outsourcing, and increasing investments by major players are some of the key factors contributing to the growth of the precision medicine software market in the Asia-Pacific region.
1. Introduction
1.1. Market Definition
1.2. Market Ecosystem
1.3. Currency
1.4. Key Stakeholders
2. Research Methodology
2.1. Research Process
2.2. Data Collection & Validation
2.2.1. Secondary Research
2.2.2. Primary Research
2.3. Market Assessment
2.3.1. Market Size Estimation
2.3.1.1. Bottom-Up Approach
2.3.1.2. Top-Down Approach
2.3.1.3. Growth Forecast
2.3.2. Market Share Analysis
2.4. Assumptions for this Study
2.5. Limitations for the Study
3. Executive Summary
4. Market Insights
4.1. Introduction
4.2. Market Dynamics
4.2.1. Drivers
4.2.1.1. Paradigm Shift in Treatment
4.2.1.2. Rising Pressure to Reduce Healthcare Costs
4.2.1.3. Scientific & Technological Advances in the Genomics Field
4.2.1.4. Growing Focus towards Providing Companion Diagnostics & Biomarkers
4.2.1.5. Rising Prevalence of Cancer
4.2.2. Restraints
4.2.2.1. Lack of Awareness about Precision Medicine Practices
4.2.2.2. Fragmented Healthcare Systems in Developing Countries
4.2.3. Opportunities
4.2.3.1. Emerging Economies
4.2.3.2. Artificial Intelligence in Precision Medicine
4.2.4. Challenges
4.2.4.1. Lack of Reimbursement for Genetic Testing & Precision Medicine
4.2.5. Covid 19 Impact Assessment
5. Global Precision Medicine Software Market, by Deployment Mode
5.1. Introduction
5.2. On-Premise
5.3. Web & Cloud-Based
6. Global Precision Medicine Software Market, by Application
6.1. Introduction
6.2. Oncology
6.3. Pharmacogenomics
6.4. Other Applications
7. Global Precision Medicine Software Market, by End User
7.1. Introduction
7.2. Healthcare Providers
7.3. Research & Government Institutes
7.4. Pharmaceutical & Biotechnological Companies
8. Precision Medicine Software Market, by Geography
8.1. Introduction
8.2. North America
8.2.1. U.S.
8.2.2. Canada
8.3. Europe
8.3.1. Germany
8.3.2. U.K.
8.3.3. France
8.3.4. Italy
8.3.5. Spain
8.3.6. Rest of Europe (RoE)
8.4. Asia-Pacific
8.4.1. Japan
8.4.2. China
8.4.3. India
8.4.4. Rest of Asia-Pacific (RoAPAC)
8.5. Latin America
8.6. Middle East & Africa
9. Competitive Landscape
9.1. Introduction
9.2. Key Growth Strategies
9.3. Competitive Benchmarking
10. Company Profiles
10.1. 2bprecise LLC (A Part of Allscripts Healthcare Solutions Inc.)
10.1.1. Business Overview
10.1.2. Financial Overview
10.1.3. Product Portfolio
10.1.4. Strategic Developments
10.2. PierianDx, Inc.
10.2.1. Business Overview
10.2.2. Product Portfolio
10.2.3. Strategic Developments
10.3. PhenoTips
10.3.1. Business Overview
10.3.2. Product Portfolio
10.3.3. Strategic Developments
10.4. Foundation Medicine, Inc.
10.4.1. Business Overview
10.4.2. Product Portfolio
10.4.3. Strategic Developments
10.5. N-of-One Inc.
10.5.1. Business Overview
10.5.2. Financial Overview
10.5.3. Product Portfolio
10.5.4. Strategic Developments
10.6. GenomOncology, LLC
10.6.1. Business Overview
10.6.2. Product Portfolio
10.6.3. Strategic Developments
10.7. Translational Software, Inc.
10.7.1. Business Overview
10.7.2. Product Portfolio
10.8. LifeOmic Health, LLC
10.8.1. Business Overview
10.8.2. Product Portfolio
10.8.3. Strategic Developments
10.9. Syapse, Inc.
10.9.1. Business Overview
10.9.2. Product Portfolio
10.9.3. Strategic Developments
10.10. Fabric Genomics, Inc.
10.10.1. Business Overview
10.10.2. Product Portfolio
10.10.3. Strategic Developments
10.11. Sophia Genetics SA
10.11.1. Business Overview
10.11.2. Product Portfolio
10.11.3. Strategic Developments
10.12. Human Longevity, Inc.
10.12.1. Business Overview
10.12.2. Product Portfolio
10.12.3. Strategic Developments
10.13. Sunquest Information Systems, Inc. (A Part of Roper Technologies, Inc.)
10.13.1. Business Overview
10.13.2. Financial Overview
10.13.3. Product Portfolio
11. Appendix
11.1. Questionnaire
11.2. Available Customization
List of Tables
Table 1 Global Precision Medicine Software Market: Impact Analysis of Market Drivers (2021–2028)
Table 2 Benefits of Precision Medicine from an Individual and Collective Perspective
Table 3 Cancer Incidence, by Type, 2020
Table 4 Global Precision Medicine Software Market: Impact Analysis of Market Restraints (2021–2028)
Table 5 Global Precision Medicine Software Market Size, by Deployment Mode, 2019–2028 (USD Million)
Table 6 Companies Offering On-Premises Precision Medicine Software
Table 7 Global On-Premise Precision Medicine Software Market Size, by Country/Region, 2019–2028 (USD Million)
Table 8 Companies Offering Cloud-Based Precision Medicine Software
Table 9 Global Cloud-Based Precision Medicine Software Market Size, by Country/Region, 2019–2028 (USD Million)
Table 10 Global Precision Medicine Software Market Size, by Application, 2019–2028 (USD Million)
Table 11 Companies Offering Precision Medicine Software for Oncology
Table 12 Global Precision Medicine Software Market Size for Oncology, by Country/Region, 2019–2028 (USD Million)
Table 13 Companies Offering Precision Medicine Software for Pharmacogenomics
Table 14 Global Precision Medicine Software Market Size for Pharmacogenomics, by Country/Region, 2019–2028 (USD Million)
Table 15 Companies Offering Precision Medicine Software for Other Applications
Table 16 Global Precision Medicine Software Market Size for Other Applications, by Country/Region, 2019–2028 (USD Million)
Table 17 Global Precision Medicine Software Market Size, by End User, 2019–2028 (USD Million)
Table 18 Strategic Developments by Key Companies
Table 19 Global Precision Medicine Software Market Size for Healthcare Providers, by Country/Region, 2019–2028 (USD Million)
Table 20 Recent Fundings
Table 21 Global Precision Medicine Software Market Size for Research & Government Institutes, by Country/Region, 2019–2028 (USD Million)
Table 22 Strategic Developments by Key Companies
Table 23 Global Precision Medicine Software Market Size for Pharmaceutical & Biotech Companies, by Country/Region, 2019–2028 (USD Million)
Table 24 Global Precision Medicine Software Market Size, by Country/Region, 2019–2028 (USD Million)
Table 25 North America: Precision Medicine Software Market Size, by Country, 2019–2028 (USD Million)
Table 26 North America: Precision Medicine Software Market Size, by Deployment Mode, 2019–2028 (USD Million)
Table 27 North America: Precision Medicine Software Market Size, by Application, 2019–2028 (USD Million)
Table 28 North America: Precision Medicine Software Market Size, by End User, 2019–2028 (USD Million)
Table 29 U.S.: Precision Medicine Software Market Size, by Deployment Mode, 2019–2028 (USD Million)
Table 30 U.S.: Precision Medicine Software Market Size, by Application, 2019–2028 (USD Million)
Table 31 U.S.: Precision Medicine Software Market Size, by End User, 2019–2028 (USD Million)
Table 32 Canada: Precision Medicine Software Market Size, by Deployment Mode, 2019–2028 (USD Million)
Table 33 Canada: Precision Medicine Software Market Size, by Application, 2019–2028 (USD Million)
Table 34 Canada: Precision Medicine Software Market Size, by End User, 2019–2028 (USD Million)
Table 35 Europe: Precision Medicine Software Market Size, by Country/Region, 2019–2028 (USD Million)
Table 36 Europe: Precision Medicine Software Market Size, by Deployment Mode, 2019–2028 (USD Million)
Table 37 Europe: Precision Medicine Software Market Size, by Application, 2019–2028 (USD Million)
Table 38 Europe: Precision Medicine Software Market Size, by End User, 2019–2028 (USD Million)
Table 39 Germany: Precision Medicine Software Market Size, by Deployment Mode, 2019–2028 (USD Million)
Table 40 Germany: Precision Medicine Software Market Size, by Application, 2019–2028 (USD Million)
Table 41 Germany: Precision Medicine Software Market Size, by End User, 2019–2028 (USD Million)
Table 42 U.K.: Precision Medicine Software Market Size, by Deployment Mode, 2019–2028 (USD Million)
Table 43 U.K.: Precision Medicine Software Market Size, by Application, 2019–2028 (USD Million)
Table 44 U.K.: Precision Medicine Software Market Size, by End User, 2019–2028 (USD Million)
Table 45 France: Precision Medicine Software Market Size, by Deployment Mode, 2019–2028 (USD Million)
Table 46 France: Precision Medicine Software Market Size, by Application, 2019–2028 (USD Million)
Table 47 France: Precision Medicine Software Market Size, by End User, 2019–2028 (USD Million)
Table 48 Number of Cancer Cases (2019 Vs. 2040)
Table 49 Italy: Precision Medicine Software Market Size, by Deployment Mode, 2019–2028 (USD Million)
Table 50 Italy: Precision Medicine Software Market Size, by Application, 2019–2028 (USD Million)
Table 51 Italy: Precision Medicine Software Market Size, by End User, 2019–2028 (USD Million)
Table 52 Spain: Precision Medicine Software Market Size, by Deployment Mode, 2019–2028 (USD Million)
Table 53 Spain: Precision Medicine Software Market Size, by Application, 2019–2028 (USD Million)
Table 54 Spain: Precision Medicine Software Market Size, by End User, 2019–2028 (USD Million)
Table 55 Covid-19 Cases in European Countries
Table 56 RoE: Precision Medicine Software Market Size, by Deployment Mode, 2019–2028 (USD Million)
Table 57 RoE: Precision Medicine Software Market Size, by Application, 2019–2028 (USD Million)
Table 58 RoE: Precision Medicine Software Market Size, by End User, 2019–2028 (USD Million)
Table 59 Asia-Pacific: Precision Medicine Software Market Size, by Country/Region, 2019–2028 (USD Million)
Table 60 Asia-Pacific: Precision Medicine Software Market Size, by Deployment Mode, 2019–2028 (USD Million)
Table 61 Asia-Pacific: Precision Medicine Software Market Size, by Application, 2019–2028 (USD Million)
Table 62 Asia-Pacific: Precision Medicine Software Market Size, by End User, 2019–2028 (USD Million)
Table 63 Japan: Precision Medicine Software Market Size, by Deployment Mode, 2019–2028 (USD Million)
Table 64 Japan: Precision Medicine Software Market Size, by Application, 2019–2028 (USD Million)
Table 65 Japan: Precision Medicine Software Market Size, by End User, 2019–2028 (USD Million)
Table 66 China: Precision Medicine Software Market Size, by Deployment Mode, 2019–2028 (USD Million)
Table 67 China: Precision Medicine Software Market Size, by Application, 2019–2028 (USD Million)
Table 68 China: Precision Medicine Software Market Size, by End User, 2019–2028 (USD Million)
Table 69 India: Precision Medicine Software Market Size, by Deployment Mode, 2019–2028 (USD Million)
Table 70 India: Precision Medicine Software Market Size, by Application, 2019–2028 (USD Million)
Table 71 India: Precision Medicine Software Market Size, by End User, 2019–2028 (USD Million)
Table 72 RoAPAC: Precision Medicine Software Market Size, by Deployment Mode, 2019–2028 (USD Million)
Table 73 RoAPAC: Precision Medicine Software Market Size, by Application, 2019–2028 (USD Million)
Table 74 RoAPAC: Precision Medicine Software Market Size, by End User, 2019–2028 (USD Million)
Table 75 Latin America: Precision Medicine Software Market Size, by Deployment Mode, 2019–2028 (USD Million)
Table 76 Latin America: Precision Medicine Software Market Size, by Application, 2019–2028 (USD Million)
Table 77 Latin America: Precision Medicine Software Market Size, by End User, 2019–2028 (USD Million)
Table 78 Middle East & Africa: Precision Medicine Software Market Size, by Deployment Mode, 2019–2028 (USD Million)
Table 79 Middle East & Africa: Precision Medicine Software Market Size, by Application, 2019–2028 (USD Million)
Table 80 Middle East & Africa: Precision Medicine Software Market Size, by End User, 2019–2028 (USD Million)
Table 81 Recent Developments, by Company, 2018–2021
List of Figures
Figure 1 Research Process
Figure 2 Key Secondary Sources
Figure 3 Primary Research Techniques
Figure 4 Key Executives Interviewed
Figure 5 Breakdown of Primary Interviews (Supply-Side & Demand-Side)
Figure 6 Market Size Estimation
Figure 7 Global Precision Medicine Software Market Size, by Deployment Mode, 2021 Vs. 2028 (USD Million)
Figure 8 Global Precision Medicine Software Market Size, by Application, 2021 Vs. 2028 (USD Million)
Figure 9 Global Precision Medicine Software Market Size, by End User, 2021 Vs. 2028 (USD Million)
Figure 10 Precision Medicine Software Market, by Region
Figure 11 Market Dynamics
Figure 12 Paradigm Shift in Treatment from One-Size-Fit-All Medicine to Precision Medicine
Figure 13 Global Genomics Annual Funding (USD Million)
Figure 14 Global Precision Medicine Software Market Size, by Deployment Mode, 2021vs 2028 (USD Million)
Figure 15 Global Precision Medicine Software Market Size, by Application, 2021–2028 (USD Million)
Figure 16 Global Precision Medicine Software Market Size, by End User, 2021–2028 (USD Million)
Figure 17 Global Precision Medicine Software Market, by Region, 2019–2028 (USD Million)
Figure 18 Geographic Snapshot: North American Precision Medicine Software Market
Figure 19 Estimated Cancer Incidence in the U.S., 2000–2030 (Number of Cases)
Figure 20 Geographic Snapshot: European Precision Medicine Software Market
Figure 21 Geographic Snapshot: Asia-Pacific Precision Medicine Software Market
Figure 22 Key Growth Strategies Adopted by Leading Players, 2018–2021
Figure 23 Precision Medicine Software: Competitive Benchmarking, by Deployment Mode
Figure 24 Precision Medicine Software: Competitive Benchmarking, by Application
Figure 25 Allscripts Healthcare Solutions, Inc: Financial Overview (2020)
Figure 26 Qiagen N.V.: Financial Overview (2020)
Figure 27 Roper Technologies, Inc.: Financial Overview (2020)
Related Reports
Medical Aesthetics Market - Global Opportunity Analysis and Industry Forecast (2022-2029)
Published Date: Jun-2022
Plasma Fractionation Market - Global Opportunity Analysis and Industry Forecast (2022-2029)
Published Date: May-2022
RWE Oncology Market - Global Opportunity Analysis And Industry Forecasts (2022-2029)
Published Date: May-2022
Surface Disinfectant Market - Global Opportunity Analysis and Industry Forecast (2022–2029)
Published Date: Apr-2022
